T issue regeneration and effective remodeling in all settings requires the effective recruitment and activation of stem cells and progenitor cells, whose progeny are capable of generating the new tissue or tissues that are required 1, 2 . As a result, the rational development of cell-based therapy strategies that target or use progenitor cell populations requires an understanding of the concentration, prevalence, biological potential, heterogeneity, and distribution of stem cells and progenitor cells that may be of use 3, 4 . The term connective tissue progenitor (CTP) has been defined and used in this effort. CTPs are defined as the heterogeneous population of "tissue-resident" stem and progenitor cells that are capable of being activated to proliferate and generate progeny that can differentiate to express ‡1 connective-tissue phenotype [5] [6] [7] [8] [9] [10] . CTPs can be assayed on the basis of colony formation. CTPs that give rise to colonies that exhibit osteoblastic differentiation can be defined as osteogenic CTPs (CTP-Os). Thus, the term CTP-O includes all potential sources of native bone-forming stem cells and progenitor cells that are clinically available today for orthopaedic tissue engineering.
Note that a colony-founding CTP in native tissues (i.e., a tissue-resident cell) whose progeny can differentiate into bone is distinct from the definition of mesenchymal stem cells (MSCs) . In contrast to the heterogeneous population of tissueresident CTPs, MSCs are defined as purified homogeneous, culture-expanded cells that retain pluripotency (i.e., the capacity to differentiate into bone, cartilage, and fat) and that also express a defined set of cell surface markers 11 . The presence of colony-founding CTP-Os in cancellous bone has been well documented 12 , making autogenous bone a reliable clinical source of osteogenic progenitors [12] [13] [14] [15] [16] [17] [18] [19] . CTP-Os can also be readily harvested by bone marrow aspiration. The iliac crest is the most anatomically accessible site for the harvest of a large volume of bone or bone marrow 9, 10, [20] [21] [22] . Aspiration techniques that limit dilution with peripheral blood, using multiple small-volume aspirations, have been defined and advocated to optimize the concentration and yield of CTPOs 6, 7, 23 . CTPs can also be isolated by the in vitro digestion of explanted tissues, such as fat 24, 25 and muscle [26] [27] [28] [29] , although the CTP populations in other tissues demonstrate different patterns of differentiation and media requirements in vitro 30 . All of these cell sources represent potential tools for tissue engineering of bone and other musculoskeletal tissues, although the biological potential of CTPs may vary by tissue source. Substantial variation has been reported from subject to subject and sample to sample. Some of this variation is related to age and sex 8 and some, to surgical site and technique 9, 10 . The extent to which the intrinsic histological or metabolic properties of local tissues are a source of variation remains to be determined.
The rational design and optimization of cell-based approaches to bone regeneration requires a baseline understanding of the concentration and prevalence of CTP-Os in specific source tissues and the sources and magnitude of variation among the tissues of individual patients. The aim of this study was to (1) define the efficiency of, and variation among individuals in, bone marrow aspiration as a means of CTP-O harvest compared with harvest from iliac cancellous bone, and (2) determine the location of CTP-Os within native cancellous bone and their distribution between the marrow space and trabecular surface tissue compartments.
Materials and Methods
Bone Marrow Aspiration and Processing T his study received institutional board approval, and the patients provided informed consent. Eight samples from bone marrow aspiration and 1 transcortical biopsy sample (7 mm in diameter) were obtained from the anterior iliac crest in 33 patients (21 female and 12 male) who were undergoing elective hip arthroplasty procedures. The median patient age was 61 years (range, 44 to 81 years). The mean body mass index (and standard deviation) was 31.6 ± 9.4 kg/m 2 (range, 22.1 to 48.2 kg/m 2 ). The inclusion and exclusion criteria are shown in the Appendix.
Samples were harvested from the ipsilateral anterior iliac crest. A 1-mm stab incision was made parallel to the Langer lines in the skin. A bone marrow aspiration needle (Lee-Lok; Lee Medical) was advanced with a lateral technique. The needle tip was advanced through the lateral cortex of the pelvis into the intramedullary cavity. The obturator was removed, and a 10-mL syringe containing 1 mL of heparin (1,000 units of Na-heparin/mL) was attached. Eight bone marrow aspirations-which, as recommended from prior work, were limited to a 2-mL volume at a given needle site to limit dilution with peripheral bloodwere performed 6 . The 8 samples were then pooled (the BMA [bone marrow aspiration] fraction). The BMA fraction then was suspended in 48 mL of alpha-minimum essential medium (a-MEM; GIBCO) containing 20 U/mL of Na-heparin and then centrifuged at 400 · g for 10 minutes 6, 8, 23 . The nucleated cell fraction (buffy coat) was isolated and resuspended in osteogenic media: a-MEM containing 10% fetal bovine serum (BioWhittaker), 50 mg/mL of sodium ascorbate (Sigma), and 1% penicillin-streptomycin (Life Technologies).
Transcortical Iliac Crest Biopsy and Cancellous-Bone Processing
After bone marrow aspirate harvest, a customized, 7-mm core biopsy needle (modified Mayo needle or Sims needle) was used to harvest a transcortical sample from the iliac crest 31 ( Fig. 1 ). This needle was advanced using a trocar and sleeve to a site approximately 2 cm posterior to the anterior superior iliac spine, i.e., 1 cm anterior to the region of aspiration. The core sample was taken using a manual technique. Each core sample was measured to calculate the iliac cancellous bone (ICB) volume, and the cortical bone ends were removed sharply (Fig. 1 ). The ICB sample was then placed into aMEM with 1% penicillin-streptomycin (Life Technologies) and minced into small pieces (1 to 2 mm in diameter) with a sharp osteotome. Cells that were mechanically liberated by the mincing process and agitation were collected and defined as the iliac crest marrow space (IC-MS) fraction 32 . Cells that remained adherent to the trabecular surface (IC-TS fraction) were then recovered by collagenase type-I digestion (Sigma), 100 U/mL for 90 minutes at 37°C. The number of cells in each fraction was counted using a hemocytometer with the nucleated cell concentration (cellularity) presented as nucleated cells · 10 6 per mL of aspirate or per g of tissue. To determine the prevalence of CTP-Os in each sample, an established CTP-O colony-forming unit (CFU) assay was used [33] [34] [35] [36] [37] . Cells from the BMA and IC-MS fractions were plated at a density of 5 · 10 5 nucleated cells in each of two 4.2-cm 2 wells on a glass chamber slide (Lab-Tek; Nalge Nunc International) in osteogenic medium (aMEM containing 10% fetal bovine serum, 10 28 M dexamethasone, 25 mg/mL ascorbate, and penicillin-streptomycin). Cells from the IC-TS fraction were plated at a density of 1 · 10 5 nucleated cells per 4.2-cm 2 chamber slide, to avoid overcrowding the CTP-O colonies because of the generally larger prevalence of CTP-Os in the IC-TS fraction, and they were cultured in the same condition as the BMA and IC-MS fractions. Cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 in air. The medium was first changed after 48 hours. Cultures were harvested and fixed on day 6 with acetone-methanol (1:1). DAPI (4ʹ,6-diamidino-2-phenylindole; Vector Laboratories), a fluorescent stain that binds strongly to AT-rich regions in DNA, was used to identify nuclei. Alkaline phosphatase staining was used as a marker of early osteoblastic differentiation 6, 8, 23, 33, 37 .
Image Acquisition and CFU Analysis
The fluorescent image of the entire chamber area (2.05 · 2.05 cm) of each sample was acquired with a 2,048 · 3,072 Quantix K6303E 12-bit digital camera (Roper Scientific) attached to a Leica DMXRA motorized fluorescent microscope equipped with a motorized x-y stage. The automated imaging system acquired 540 individual images (20 columns · 27 rows), covering the entire chamber surface. These 512 · 768, 8-bit gray-level images were acquired using a · 10 objective (pixel size = 1.78 mm). Nuclei stained with DAPI allowed discrete localization of CTP colonies and the overlay of anteroposterior images (Fig. 2) . Fig. 1 -B Sagittal view of the iliac crest depicting the transcortical bone core sample (7 mm in diameter) harvested with a customized biopsy needle. 1675
The quantitative characterization of each colony (cell number, colony surface area, cell density, and alkaline phosphatase area) was performed using a custom software suite (Colonyze; Cleveland Clinic) 37 . A colony was defined as a group of ‡8 cells at day 6, based on proximity suggesting a common founding cell (i.e., CTP) [33] [34] [35] [36] . CTP-O prevalence was defined as the number of colonies that formed per million cells plated 37 . To compare the in vitro performance of the progeny of the founding CTP, we measured and compared 3 colony-level metrics: cells per colony, cell density within each colony (cells per mm 2 ), and the area of alkaline phosphatase expression per cell (mean area of alkaline phosphatase-positive pixels/cell presented as mm 2 /cell). These provided metrics of relative proliferation, migration, and early osteoblastic differentiation 23 .
Statistical Analysis
The primary outcomes for each sample fraction (BMA, IC-MS, and IC-TS) were cellularity, prevalence of CTP-Os, and CTP-O 1676
concentration. The total content of the ICB samples (ICTotal) was calculated as the sum of cells or CTP-Os from the IC-MS and IC-TS fractions for each subject. An analysis of variance (ANOVA) was used to compare the fractions. The patient effect was included as a random factor and Tukey tests were used to compare the means. Because of the skewed distributions, a log transformation was used to carry out the analyses of the 3 outcomes. Back transformations were used to allow results to be reported as geometric means and corresponding 95% confidence intervals (CIs). All analyses were performed using JMP 8.0 (SAS Institute). 1677
Results

Nucleated Cell Concentration in BMA and ICB Samples
T he geometric mean nucleated cell concentration in the IC-MS fraction was 256 ± 196 · 10 6 nucleated cells/mL, which was significantly higher than in the BMA fraction (21.9 ± 8.9 · 10 6 nucleated cells/mL) and IC-TS fraction (18.1 ± 18.9 · 10 6 nucleated cells/mL) (p < 0.001) ( Table I ). The nucleated cell concentration was highly variable among subjects, particularly with respect to the IC-MS fraction. The IC-MS fraction, therefore, dominated the variation in the calculation of IC-Total nucleated cell concentration ( Figs. 3  and 4 ; see Appendix). 
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T Overall, the mean contribution of IC-TS-derived CTP-Os to the IC-Total CTP-Os was 0.8 (95% CI, 0.50 to 1.1). However, this ratio was highly variable among subjects. Seventeen (52%) of the subjects had more CTP-Os contributed by TS cells, and 16 (48%) had more CTP-Os contributed by MS cells ( Fig. 8 ; see Appendix). The median concentration of CTP-Os in the ICB (combining MS and TS fractions) was only 3.04 ± 1.1-fold greater than that in BMA (4,265 compared with 1,402 CTP/mL; p = 0.00004).
Comparison of CTP Colony-Level Metrics Among BMA, IC-MS, and IC-TS Fractions
As shown in Table I , colonies founded by CTP-Os obtained by bone marrow aspiration were more proliferative than were colonies founded by CTP-Os obtained from the IC-MS fraction or the IC-TS fraction (58.3 cells per colony compared with 35.5 and 38.2 cells per colony, respectively; p = 0.013). There were no significant differences in cell density or alkaline phosphatase activity among the 3 fractions. However, there was a strong trend toward lower cell density in the IC-MS-derived colonies (p = 0.051) and greater alkaline phosphatase activity in the IC-TS-derived colonies (p = 0.064).
Discussion
T his study was designed with 2 aims, namely, to (1) define the current efficiency of, and variation among individuals in, bone marrow aspiration as a means of CTP-O harvest compared with harvest from iliac cancellous bone, and (2) determine the location of CTP-Os within native cancellous bone and their distribution between the marrow-space and Regarding aim 1 (Figs. 3, 5 , and 7), this study allowed the direct comparison of the yield of cells and CTP-Os using bone marrow aspiration versus open harvest of native iliac crest cancellous bone tissue. These data demonstrate wide variation in the concentration of cells and CTP-Os among individuals. Bone marrow aspiration efficacy and dilution can be calculated from CTP-O concentration data. Since blood contains virtually no colony-forming cells 38 , all of the colonies detected in bone marrow aspiration with this assay should represent CTPs with various capacities for osteogenic differentiation that are derived from ICB (either the MS or TS fraction). Because the geometric mean CTP-O concentration for the entire ICB across all subjects was 3,215 CTP-Os per mL and the mean for the BMA fraction was 835 CTP-Os per mL, the BMA fraction therefore contained a number of CTP-Os that represent roughly 26% of the CTP-Os present in the ICB. The remaining volume from bone marrow aspiration, a mean of 740 mL per mL of aspirate, would then be blood. This calculation provides an estimate of a roughly 4-fold dilution with peripheral blood. In fact, because of the skewing in the data, the most accurate calculation of mean dilution is derived from the geometric mean data for total CTP-O concentration for the BMA fraction compared with CTP-O concentration for the IC-Total, which yields an actual geometric mean dilution of 3.04 ± 1.1-fold.
Regarding aim 2 (Figs. 4, 6 , and 8), we found that the location and distribution of cells and CTP-Os within these 2 tissue compartments varied widely from subject to subject. Overall, >90% of the nucleated cells in ICB can be collected by mincing and agitation (the IC-MS fraction), yielding a mean of 256 million cells per mL of ICB in this 33-patient cohort. Following the harvest of cells by mechanical means, an additional fraction of cells (<10% of the cells in ICB) can be released by enzymatic digestion to liberate them from the trabecular surface (IC-TS fraction), yielding a mean of 18 million cells per mL of ICB. Because of the >10-fold higher prevalence of CTP-Os in the IC-TS fraction, across all subjects, a mean of 63.5% of CTP-Os were derived from the IC-TS fraction, a geometric mean of 1,155 CTPs per mL of ICB. This is comparable with some reports involving rodent bone comparing yields of femoral irrigation and digestion [39] [40] [41] . These data indicate that, in general, more than half of all CTPs were resident on, or entrapped in, tissue near the trabecular surface. However, few patients overall fit this neat picture. In this study, 16 (48%) of the patients derived more CTP-Os from the IC-MS fraction than from the IC-TS fraction, while 85% of those had more than two-thirds of CTP-Os from the IC-MS fraction. This variation has 2 important implications for tissue-engineering strategies involving the harvest and processing of cells and CTP-Os from iliac cancellous bone. First, neither the IC-MS nor the IC-TS fraction can be neglected. Harvest and processing methods should include strategies for capture of CTP-Os from both tissue fractions, removing the possibility of discarding a patient's primary CTP-O reservoir by selecting one or the other. Second, further work needs to be conducted to understand the physiological mechanism of this variation in the distribution of CTP-Os within iliac cancellous bone. The distribution or dominant location of CTP-Os may have clinical implications and diagnostic or predictive value.
We did not demonstrate definitive differences between CTP-Os derived from the BMA, MS, or TS tissue sources. Secondary analysis of the biological performance of CTP-Os derived from BMA, MS, or TS fractions indicated more rapid proliferation among the clonal progeny of BMA-derived CTP-Os. Trends were seen suggesting decreased cell density among the clonal progeny of MS-derived CTP-Os and an increase in alkaline phosphatase expression among clonal progeny of TS-derived CTP-Os. These findings could suggest that TS-derived CTP-Os could either be more osteogenic or more rapidly express osteogenic differentiation than MSderived CTP-Os. Analysis of a larger dataset and in vitro assessment over longer time periods will be needed to determine if these trends are generalizable. Moreover, differences between MS and TS-derived CTPs may represent underlying differences in the biological potential among the colony-founding CTP-Os in these sites. It is also possible for differences in performance to arise as a result of exposure to hematopoietic cells in the MS fraction (either secreted factors, cell-cell contact, or degradation products). Differences could also arise due to secondary effects of the enzymatic digestion to which TS cells are exposed. Similarly, BMAderived CTP-Os and their progeny, which demonstrated larger colony size than either the MS or TS-derived colonies, may be influenced by the trauma of bone marrow aspiration and/or greater exposure to serum, platelets, and mature circulating cells (monocytes, macrophages, lymphocytes, platelets, or erythrocytes) in the early culture environment, prior to media change at 48 hours. Therefore, at present, we consider the biological potential of CTP-Os derived from BMA, MS, or TS fractions to be comparable, until proven otherwise.
In conclusion, our data suggest that bone marrow aspiration, limiting aspiration volume to 2 mL per needle position, is an effective method for the harvest of CTP-Os from the iliac crest. However, even using this optimized method, bone marrow aspiration is still associated with a 3 to 4-fold dilution of CTP-Os with peripheral blood. CTP-Os can be found among cells in the marrow space that are easily separated by agitation and among cells on the trabecular surface that must be removed by enzymatic digestion. Because individuals vary widely with respect to the predominant location of CTP-Os, neither the MS nor TS fractions in cancellous bone can be neglected as a potential source of CTP-Os in current or future clinical applications. These data quantify the magnitude of opportunity that exists to improve on the efficiency of current bone marrow aspirate harvest methods.
